Optimal sampling schedules for kidney dosimetry for 177Lu-PSMA therapy

被引：0

作者：

Rinscheid, Andreas ^{[2
,3
]}

Allmann, Anne ^{[1
]}

Allmann, Jakob ^{[1
]}

Eberhardt, Nina ^{[2
]}

Eiber, Matthias ^{[1
]}

Kletting, Peter ^{[2
,3
]}

Beer, Ambros ^{[2
]}

Glatting, Gerhard ^{[2
,3
]}

机构：

[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, Munich, Germany

[2] Ulm Univ, Dept Nucl Med, Ulm, Germany

[3] Ulm Univ, Dept Nucl Med, Med Radiat Phys, Ulm, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

266

引用

页数：1

共 3 条

[1] The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides [J].

Begum, Nusrat J. ;

Thieme, Anne ;

Eberhardt, Nina ;

Tauber, Robert ;

D'Alessandria, Calogero ;

Beer, Ambros J. ;

Glatting, Gerhard ;

Eiber, Matthias ;

Kletting, Peter .

JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) :929-933

[2] Modeling and Predicting Tumor Response in Radioligand Therapy [J].

Kletting, Peter ;

Thieme, Anne ;

Eberhardt, Nina ;

Rinscheid, Andreas ;

D'Alessandria, Calogero ;

Allmann, Jakob ;

Wester, Hans-Juergen ;

Tauber, Robert ;

Beer, Ambros J. ;

Glatting, Gerhard ;

Eiber, Matthias .

JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (01) :65-70

[3] Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides [J].

Kletting, Peter ;

Schuchardt, Christiane ;

Kulkarni, Harshad R. ;

Shahinfar, Mostafa ;

Singh, Aviral ;

Glatting, Gerhard ;

Baum, Richard P. ;

Beer, Ambros J. .

PLOS ONE, 2016, 11 (09)

← 1 →